Cogenital Heart Disease Associated With Selective Serotonin Rcuptake

Wichman, Christina L.; Moore, Katherine M.; Lang, Tara R.; St. Sauver, Jennifer L.; Heise Jr, Robert H.; Watson, William J.
January 2009
Mayo Clinic Proceedings;Jan2009, Vol. 84 Issue 1, p23
Academic Journal
OBJECTIVE: To determine the risk of congenital cardiac abnormalities associated with use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy. PATIENTS AND METHODS: We conducted a retrospective review of the medical records of all pregnant women presenting at Mayo Clinic's site In Rochester, MN, from January 1, 1993, to July 15, 2005, and Identified 25,214 deliveries. A total of 808 mothers were treated with SSRIs at some point during their pregnancy. We reviewed the medical records of the newborns exposed to SSRIs during pregnancy to analyze their outcomes, specifically for congenital heart disease and persistent pulmonary hypertension of the newborn. RESULTS: Of the study patients, 808 (3.2%) took an SSRI at some point during the antenatal period. Of the 25,214 deliveries, 208 newborns (0.8%) were diagnosed as having congenital heart disease. Of the 808 women exposed to SSRI during pregnancy, 3 (0.4%) had congenital heart disease compared with 205 (0.8%) of the 24,406 women not exposed to an SSRI (P=-.23). Of the total number of deliveries, 16 newborns were diagnosed as having persistent pulmonary hypertension of the newborn, none of whom had exposure to SSRIs (P>.99). CONCLUSION: Our data are reassuring regarding the safety of using SSRIs during pregnancy.


Related Articles

  • SSRIs Associated With Low Rate of Birth Defects, Studies Show.  // OB/GYN Clinical Alert;Aug2007, Vol. 24 Issue 4, p1 

    The article reports on the association of selective serotonin reuptake inhibitors (SSRI) with a low rate of birth defects according to two studies published in the "New England Journal of Medicine." The first study conducted by Boston University and Harvard researchers in the U.S. revealed that...

  • Study finds link between SSRIs and congenital heart defects.  // Reactions Weekly;10/3/2009, Issue 1272, p1 

    The article discusses research in the U.S. and Denmark on the association of selective serotonin reuptake inhibitor (SSRI) with the prevalence of congenital heart defects. It references a study by C. Chamber, published in the September 2009 issue of the "British Medical Journal." In the first...

  • SSRIs Associated With Low Rate of Birth Defects, Studies Show. Elliott, William T. // Clinical Cardiology Alert;Aug2007 Pharmacology Watch, p1 

    The article reports on two studies in the "New England Journal of Medicine" which revealed the association of selective serotonin reuptake inhibitors (SSRIs) with a low rate of birth defects. Researchers from Boston University and Harvard found that the use of SSRIs was not associated with...

  • Continuing medical education: SSRIs and pregnancy. Andrade, Chittaranjan // Indian Journal of Psychiatry;Jan-Mar2010, Vol. 52 Issue 1, p83 

    The article discusses the impact of selective serotonin reuptake inhibitors (SSRI) on maternal conception. It notes that SSRI increases the susceptibility of congenital heart malformations on infants. It notes that voluntary withdrawal of antidepressant before pregnancy is associated with...

  • Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark. Jordan, Sue; Morris, Joan K.; Davies, Gareth I.; Tucker, David; Thayer, Daniel S.; Luteijn, Johannes M.; Morgan, Margery; Garne, Ester; Hansen, Anne V.; Klungsøyr, Kari; Engeland, Anders; Boyle, Breidge; Dolk, Helen // PLoS ONE;12/1/2016, Vol. 11 Issue 12, p1 

    Background: Hypothesised associations between in utero exposure to selective serotonin reuptake inhibitors (SSRIs) and congenital anomalies, particularly congenital heart defects (CHD), remain controversial. We investigated the putative teratogenicity of SSRI prescription in the 91 days either...

  • A Prozac pregnancy? AOOSTA, KIM SCHWORM // Fit Pregnancy;Dec2012/Jan2013, Vol. 19 Issue 5, p19 

    The article discusses ill effects of taking antidepressants during pregnancy. It has been informed that studies suggest that the most commonly prescribed antidepressant Selective Serotonin Reuptake Inhibitors (SSRIs) during pregnancy could result in an increased risk of high blood pressure and...

  • Use of SSRIs during pregnancy. Elliott, William T. // Infectious Disease Alert;Nov2009, Vol. 29 Issue 2, p1 

    The article reports on the risk of septal heart defects among children whose mothers used selective serotonin reuptake inhibitors (SSRIs) sertraline and citalopram use during pregnancy according to a study conducted in Denmark. The study found that sertraline has the highest risk among SSRIs...

  • Adverse effects of SSRIs taken during pregnancy. Thomas, Jack // Australian Journal of Pharmacy;Mar2010, Vol. 91 Issue 1078, p75 

    The article reports on the study that investigates the effect of intrauterine selective serotonin reuptake inhibitor (SSRI) exposure on pregnancy, which reveals that utero-exposed newborns had increased risk of admission to the neonatal intensive care unit.

  • Teratogenic risk of SSRIs used during pregnancy. Huffman, Grace Brooke // American Family Physician;7/1/1998, Vol. 58 Issue 1, p243 

    Presents a summary of the article `Pregnancy Outcome Following Maternal Use of the New Selective Serotonin Reuptake Inhibitors,' by N.A. Kulin and others, which was published in the February 25, 1998, issue of the `Journal of the American Medical Association.' Examination of the pregnancy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics